Chemotherapy: what progress in the last 5 years?
Hamilton
Anne
A
Sydney Cancer Centre and University of Sydney, Australia.
Hortobagyi
Gabriel
G
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000556:secondary; D004358:Drug Therapy / Q000639:trends*; D005260:Female; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D000068878:Trastuzumab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab